Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000246647 | SCV000302901 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001512136 | SCV000603960 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001512136 | SCV001719490 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001702379 | SCV001933050 | benign | Hemolytic anemia due to hexokinase deficiency | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701886 | SCV001933051 | benign | Neurodevelopmental disorder with visual defects and brain anomalies | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701885 | SCV001933053 | benign | Charcot-Marie-Tooth disease type 4G | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701954 | SCV001933054 | benign | Retinitis pigmentosa 79 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888654 | SCV004706911 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001512136 | SCV005318903 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000246647 | SCV001924628 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000246647 | SCV001962961 | benign | not specified | no assertion criteria provided | clinical testing |